An observational study in Sensory Processing Disorder and Neurodevelomental Disorders, sponsored by Yeditepe University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 3 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-18.
Sponsored by Yeditepe University · Observational
The aim of the study is to investigate the long-term effects of ASI-based and hybrid neurodevelopmental counseling services on the variables of the Ayres Sensory Integration Assessment Test in children with neurodevelopmental disorders.
After application to the YUGEM Sensory Perception Motor Unit, the child and family will undergo a preliminary assessment. Following the necessary interviews and psychiatric consultation, specialists will decide whether the child is suitable for the Evaluation in Ayres Sensory Integration (EASI).
Children who are considered suitable for the EASI assessment will be evaluated through a multidisciplinary approach. The data obtained from the assessment will be analyzed using computer-based statistical software, and the results will be reviewed by the specialists. Based on these results, the frequency, duration, and delivery method of sensory integration therapy will be determined according to the needs of the child and family.
Neurodevelopmentally focused therapy counseling based on Ayres Sensory Integration principles will be planned either face-to-face or remotely, as appropriate for the child and family. After this decision, a meeting will be held with the family to plan the child's therapy process. There will be a 6-month therapy-counseling process.
352 studies on the registry are indexed under Neurodevelopmental Disorders; 141 are open to participants now.
This study's planned enrollment of 16 is below the median of 200 across 133 observational studies indexed under Neurodevelopmental Disorders.
Browse Neurodevelopmental Disorders studies →Yeditepe University is the lead sponsor of 131 studies on the registry; 29 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will consist of children aged 3 to 12 years with diagnosed or suspected neurodevelopmental problems who apply to the YUGEM Sensory Perception Motor Unit at Yeditepe University. Children referred for neurodevelopmental follow-up and considered suitable for the Evaluation in Ayres Sensory Integration assessment will be included in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Children aged 3 to 12 years with neurodevelopmental disorders who applied to the YUGEM Sensory Perception Motor Unit and are considered suitable for the Evaluation in Ayres Sensory Integration assessment.
The Evaluation of Ayres Sensory Integration (EASI)
The Evaluation of Ayres Sensory Intergation test measures sensory perception, postural/ocular/bilateral motor integration, praxis, and sensory reactivity in a way that minimizes the effects of culture, language comprehension, and prior experience. The EASI tests are designed for children aged 3-12 and will be administered by appropriately trained professionals.
Time frame: 4 Weeks
Pediatric Sensory Profile
This is a measure consisting of three main sections used in children. These are; sensory processing, modulation and behavioral and emotional responses. The subgroups of each main section (14 sections in total, 125 questions) are tested. This scale is administered by the caregiver.
Time frame: 4 weeks
Plan to share: Undecided — It's not decided.
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for Jul 2026, 0 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Neurodevelopmental Disorders →